SlideShare a Scribd company logo
1 of 2
Download to read offline
I EQUITIES I
I GAIL (INDIA) LTD I
Special Report
WAY2WEALTH Brokers Private Ltd.,
-
Email: research@way2wealth.com website: www.way2wealth.com
No. 14, Frontline Granduer, Walton Road, Bangalore-560001
Way2wealth Research is also available on Bloomberg WTWL <GO>
16 June 2015
Given below are the monthly and weekly charts of GAIL (INDIA) LTD which illustrates that the
counter has been in the correction mode right from Oct 2014 till the month of April 2015. During
the process, the stock shaved off more than 35% from the all-time high of 551.90 and made the
immediate swing low of 353.35. Now, at this point in time the stock is once again above the 400
mark. The important point to notice over here is that the prices inverted exactly from the
multiple support zone of 357 – 347 which has been braced with many crucial stalling points like
’89 –Month EMA’ and also the 61.8% FIB retracement level of the entire move from 272 to
551.90. After reversing from the discussed stage, stock has made ‘Higher High and Higher Low’
on the weekly chart which indicates likelihood of change in trend.
In today’s session, a move above landmark of 400 has resulted in a bullish pattern which resembles
a ‘Cup and Handle’. Also, the counter managed to cross the hurdle of ’89 – EMA’ on weekly as
well as daily chart. Coming back to the monthly chart, we have also displayed the ‘Heikin-Ashi’
chart of GAIL. It is evident from the given chart that the ‘Heikin-Ashi’ candle is changing its color
from RED to BLUE. This is a super bullish sign coupled with positive placement of momentum
oscillators. Due to the mentioned technical evidences we are of the opinion that the stock has
many rationale to show a sharp upside momentum in the upcoming sessions. Therefore, we
advise traders to go long in the GAIL above 404 for an upside target of 480 in medium term.
Investment Strategy:
Buy ONLY above 404 with a stop loss of 368 for a Target of 480.
Risk/return ratio: 1:2.1
Special Report
I GAIL (INDIA) LTD I
WAY2WEALTH Brokers Private Ltd., CIN U67120KA2000PTC027628
-
Email: research@way2wealth.com website: www.way2wealth.com
No. 14, Frontline Granduer, Walton Road, Bangalore-560001
Way2wealth Research is also available on Bloomberg WTWL <GO>
Disclaimer
Analyst Certification: I, Mehul Kothari, the research analyst and author of this report, hereby certify that the views expressed in this
research report accurately reflect our personal views about the subject securities, issuers, products, sectors or industries. It is also
certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific
recommendations or views in this research. The analyst(s), principally responsible for the preparation of this research report, receives
compensation based on overall revenues of the company (Way2Wealth Brokers Private Limited, hereinafter referred to as Way2Wealth)
and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations.
It is confirmed that Mehul Kothari, the author of this report has not received any compensation from the companies mentioned in the
report in the preceding 12 months. Our research professionals are paid in part based on the profitability of Way2Wealth, which include
earnings from other business. Neither Way2Wealth nor its directors, employees, agents or representatives shall be liable for any
damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in
connection with the use of the information contained in this report.
Disclaimer
This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation
advice to you. Way2Wealth is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy
or sell any security or product, or to engage in or refrain from engaging in any such transaction. The contents of this material are
general and are neither comprehensive nor appropriate for every individual and are solely for the informational purposes of the
readers. This material does not take into account the specific objectives, financial situation or needs of an individual/s or a
Corporate/s or any entity/s.
This research has been prepared for the general use of the clients of the Way2Wealth and must not be copied, either in whole or in
part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose
the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive
this report at the same time. Way2Wealth will not treat recipients as customers by virtue of their receiving this report. The distribution
of this document in other jurisdictions may be restricted by the law applicable in the relevant jurisdictions and persons into whose
possession this document comes should inform themselves about, and observe any such restrictions.
The report is based upon information obtained from sources believed to be reliable, but we do not make any representation or
warranty that it is accurate, complete or up to date and it should not be relied upon as such. Way2Wealth or any of its affiliates or
employees makes no warranties, either express or implied of any kind regarding any matter pertaining to this report, including, but not
limited to warranties of suitability, fitness for a particular purpose, accuracy, timeliness, completeness or non-infringement. We
accept no obligation to correct or update the information or opinions in it. Way2Wealth or any of its affiliates or employees shall not
be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained
in this report. The recipients of this report should rely on their own investigations. In no event shall Way2Wealth be liable for any
damages of any kind, including, but not limited to, indirect, special, incidental, consequential, punitive, lost profits, or lost
opportunity, whether or not Way2Wealth has advised of the possibility of such damages.
This material contains statements that are forward-looking; such statements are based upon the current beliefs and expectations and
are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.
These uncertainties include but are not limited to: the risk of adverse movements or volatility in the securities markets or in interest or
foreign exchange rates or indices; adverse impact from an economic slowdown; downturn in domestic or foreign securities and trading
conditions or markets; increased competition; unfavorable political and diplomatic developments; change in the governmental or
regulatory policies; failure of a corporate event and such others. This is not an offer to buy or sell or a solicitation of an offer to buy or
sell any security or instrument or to participate in any particular trading strategy. No part of this material may be copied or duplicated
in any form by any means or redistributed without the written consent of Way2Wealth. In no event shall any reader publish, retransmit,
redistribute or otherwise reproduce any information provided by Way2Wealth in any format to anyone. Way2Wealth and its affiliates,
officers, directors and employees including persons involved in the preparation or issuance of this report may from time to time have
interest in securities / positions, financial or otherwise in the securities related to the information contained in this report.
To enhance transparency, Way2Wealth has incorporated a Disclosure of Interest Statement in this document. This should, however, not
be treated as endorsement of the views expressed in the report.

More Related Content

What's hot

Morning tea 10 06-2016
Morning tea 10 06-2016Morning tea 10 06-2016
Morning tea 10 06-2016Choice Equity
 
Choice - Morning Tea
Choice - Morning TeaChoice - Morning Tea
Choice - Morning Teachoice broking
 
Welcome to The World of EV's
Welcome to The World of EV'sWelcome to The World of EV's
Welcome to The World of EV'srayanwarner
 
Choice - Morning Tea
Choice - Morning TeaChoice - Morning Tea
Choice - Morning Teachoice broking
 
Morning tea 19 12-2016
Morning tea 19 12-2016Morning tea 19 12-2016
Morning tea 19 12-2016choice broking
 
Daily equity report 16 april 2019
Daily equity report 16 april 2019Daily equity report 16 april 2019
Daily equity report 16 april 2019pihusharma29
 
Corporate presentation november 2016 final
Corporate presentation november 2016 finalCorporate presentation november 2016 final
Corporate presentation november 2016 finalcorpaveda2015
 
Choice-Morning Tea 30-10-2015
Choice-Morning Tea 30-10-2015Choice-Morning Tea 30-10-2015
Choice-Morning Tea 30-10-2015choice broking
 
Morning Tea 01-09-2015
Morning Tea 01-09-2015Morning Tea 01-09-2015
Morning Tea 01-09-2015choice broking
 
Morning tea 14 09-2016
Morning tea 14 09-2016Morning tea 14 09-2016
Morning tea 14 09-2016Choice Equity
 
Morning tea 22 03-2017
Morning tea 22 03-2017Morning tea 22 03-2017
Morning tea 22 03-2017Choice Equity
 
Fortis Healthcare Limited – Composite Scheme
Fortis Healthcare Limited – Composite SchemeFortis Healthcare Limited – Composite Scheme
Fortis Healthcare Limited – Composite SchemeFortis Healthcare
 
Corporate presentation january 2017 v2
Corporate presentation   january 2017 v2Corporate presentation   january 2017 v2
Corporate presentation january 2017 v2corpaveda2015
 
Aveda energy investor presentation july 2014 final
Aveda energy investor presentation july 2014 finalAveda energy investor presentation july 2014 final
Aveda energy investor presentation july 2014 finalAvedaEnergy
 
Morning tea 21 03-2017
Morning tea 21 03-2017Morning tea 21 03-2017
Morning tea 21 03-2017Choice Equity
 
Aveda energy investor presentation january 2014
Aveda energy investor presentation january 2014Aveda energy investor presentation january 2014
Aveda energy investor presentation january 2014AvedaEnergy
 
Morning tea 24 -11-2015
Morning tea 24 -11-2015Morning tea 24 -11-2015
Morning tea 24 -11-2015choice broking
 
Morning tea 26 08-2016
Morning tea 26 08-2016Morning tea 26 08-2016
Morning tea 26 08-2016Choice Equity
 
Derivatives report 27 oct-2010
Derivatives report 27 oct-2010Derivatives report 27 oct-2010
Derivatives report 27 oct-2010Angel Broking
 

What's hot (20)

Morning tea 10 06-2016
Morning tea 10 06-2016Morning tea 10 06-2016
Morning tea 10 06-2016
 
Choice - Morning Tea
Choice - Morning TeaChoice - Morning Tea
Choice - Morning Tea
 
Welcome to The World of EV's
Welcome to The World of EV'sWelcome to The World of EV's
Welcome to The World of EV's
 
Choice - Morning Tea
Choice - Morning TeaChoice - Morning Tea
Choice - Morning Tea
 
Morning tea 19 12-2016
Morning tea 19 12-2016Morning tea 19 12-2016
Morning tea 19 12-2016
 
Daily equity report 16 april 2019
Daily equity report 16 april 2019Daily equity report 16 april 2019
Daily equity report 16 april 2019
 
Corporate presentation november 2016 final
Corporate presentation november 2016 finalCorporate presentation november 2016 final
Corporate presentation november 2016 final
 
Choice-Morning Tea 30-10-2015
Choice-Morning Tea 30-10-2015Choice-Morning Tea 30-10-2015
Choice-Morning Tea 30-10-2015
 
Morning Tea 01-09-2015
Morning Tea 01-09-2015Morning Tea 01-09-2015
Morning Tea 01-09-2015
 
Morning tea 14 09-2016
Morning tea 14 09-2016Morning tea 14 09-2016
Morning tea 14 09-2016
 
Morning tea 22 03-2017
Morning tea 22 03-2017Morning tea 22 03-2017
Morning tea 22 03-2017
 
Fortis Healthcare Limited – Composite Scheme
Fortis Healthcare Limited – Composite SchemeFortis Healthcare Limited – Composite Scheme
Fortis Healthcare Limited – Composite Scheme
 
Corporate presentation january 2017 v2
Corporate presentation   january 2017 v2Corporate presentation   january 2017 v2
Corporate presentation january 2017 v2
 
Aveda energy investor presentation july 2014 final
Aveda energy investor presentation july 2014 finalAveda energy investor presentation july 2014 final
Aveda energy investor presentation july 2014 final
 
Morning tea 21 03-2017
Morning tea 21 03-2017Morning tea 21 03-2017
Morning tea 21 03-2017
 
Aveda energy investor presentation january 2014
Aveda energy investor presentation january 2014Aveda energy investor presentation january 2014
Aveda energy investor presentation january 2014
 
Hcs 1 q13_ir_eng
Hcs 1 q13_ir_engHcs 1 q13_ir_eng
Hcs 1 q13_ir_eng
 
Morning tea 24 -11-2015
Morning tea 24 -11-2015Morning tea 24 -11-2015
Morning tea 24 -11-2015
 
Morning tea 26 08-2016
Morning tea 26 08-2016Morning tea 26 08-2016
Morning tea 26 08-2016
 
Derivatives report 27 oct-2010
Derivatives report 27 oct-2010Derivatives report 27 oct-2010
Derivatives report 27 oct-2010
 

Viewers also liked

SIX Principles CIRCULAR
SIX Principles CIRCULARSIX Principles CIRCULAR
SIX Principles CIRCULARAnimesh Ikshit
 
The representations of serial killers
The representations of serial killersThe representations of serial killers
The representations of serial killersSouth Sefton College
 
OpenTerms Syntax Issue 02
OpenTerms Syntax Issue 02OpenTerms Syntax Issue 02
OpenTerms Syntax Issue 02Noel Fessey
 
Presentacion proyecto
Presentacion proyectoPresentacion proyecto
Presentacion proyectoAnghelo Loayza
 
KyleeEgbertPortfolio
KyleeEgbertPortfolioKyleeEgbertPortfolio
KyleeEgbertPortfolioKylee Egbert
 
Asian architecture- Implementation of Sun Shading strategies in 8D House
Asian architecture- Implementation of Sun Shading strategies in 8D HouseAsian architecture- Implementation of Sun Shading strategies in 8D House
Asian architecture- Implementation of Sun Shading strategies in 8D HouseWmin fOO
 
Interactive Lecturing: La clase magistral interactiva
Interactive Lecturing: La clase magistral interactivaInteractive Lecturing: La clase magistral interactiva
Interactive Lecturing: La clase magistral interactivaPablo Cesar Garcia Sanchez
 

Viewers also liked (10)

SIX Principles CIRCULAR
SIX Principles CIRCULARSIX Principles CIRCULAR
SIX Principles CIRCULAR
 
EZQUEMATIZACION DE LA NORMA ISO-9001 2008
EZQUEMATIZACION DE LA NORMA ISO-9001 2008EZQUEMATIZACION DE LA NORMA ISO-9001 2008
EZQUEMATIZACION DE LA NORMA ISO-9001 2008
 
Stuart Hall Representation
Stuart Hall Representation Stuart Hall Representation
Stuart Hall Representation
 
The representations of serial killers
The representations of serial killersThe representations of serial killers
The representations of serial killers
 
OpenTerms Syntax Issue 02
OpenTerms Syntax Issue 02OpenTerms Syntax Issue 02
OpenTerms Syntax Issue 02
 
arvind resume
arvind resumearvind resume
arvind resume
 
Presentacion proyecto
Presentacion proyectoPresentacion proyecto
Presentacion proyecto
 
KyleeEgbertPortfolio
KyleeEgbertPortfolioKyleeEgbertPortfolio
KyleeEgbertPortfolio
 
Asian architecture- Implementation of Sun Shading strategies in 8D House
Asian architecture- Implementation of Sun Shading strategies in 8D HouseAsian architecture- Implementation of Sun Shading strategies in 8D House
Asian architecture- Implementation of Sun Shading strategies in 8D House
 
Interactive Lecturing: La clase magistral interactiva
Interactive Lecturing: La clase magistral interactivaInteractive Lecturing: La clase magistral interactiva
Interactive Lecturing: La clase magistral interactiva
 

Similar to Way2Wealth's technical pick: Go long on GAIL only above 404 for target of 480

Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145
Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145 Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145
Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145 IndiaNotes.com
 
OKYO Corporate Presentation May 2022
OKYO Corporate Presentation May 2022 OKYO Corporate Presentation May 2022
OKYO Corporate Presentation May 2022 RedChip Companies, Inc.
 
Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019Axis Direct
 
Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019Axis Direct
 
Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019Axis Direct
 
Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018Axis Direct
 
Daily Derivatives Report:22 November 2018
Daily Derivatives Report:22 November 2018Daily Derivatives Report:22 November 2018
Daily Derivatives Report:22 November 2018Axis Direct
 
Daily Derivatives Report:11 January 2019
Daily Derivatives Report:11 January 2019Daily Derivatives Report:11 January 2019
Daily Derivatives Report:11 January 2019Axis Direct
 
Daily Derivatives Report:02 January 2019
Daily Derivatives Report:02 January 2019Daily Derivatives Report:02 January 2019
Daily Derivatives Report:02 January 2019Axis Direct
 
Weekly Derivatives Report :28 January 2019
Weekly Derivatives Report :28 January 2019Weekly Derivatives Report :28 January 2019
Weekly Derivatives Report :28 January 2019Axis Direct
 
Beat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century FinancialBeat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century Financialrayanwarner
 
Beat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century FinancialBeat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century Financialrayanwarner
 
Weekly Derivatives Report :29 October 2018
Weekly Derivatives Report :29 October 2018Weekly Derivatives Report :29 October 2018
Weekly Derivatives Report :29 October 2018Axis Direct
 
Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019Axis Direct
 
Mr. Sumeet Bagadia View on Asian Paints
Mr. Sumeet Bagadia View on Asian PaintsMr. Sumeet Bagadia View on Asian Paints
Mr. Sumeet Bagadia View on Asian Paintschoice broking
 
SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth IndiaNotes.com
 
Daily Derivatives Report:24 October 2018
Daily Derivatives Report:24 October 2018Daily Derivatives Report:24 October 2018
Daily Derivatives Report:24 October 2018Axis Direct
 
Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019Axis Direct
 

Similar to Way2Wealth's technical pick: Go long on GAIL only above 404 for target of 480 (20)

Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145
Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145 Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145
Amtek India: Buy at 105 with a stop loss of 88 for a Target of 145
 
OKYO Investors Slides 2020
OKYO Investors Slides 2020OKYO Investors Slides 2020
OKYO Investors Slides 2020
 
OKYO Corporate Presentation May 2022
OKYO Corporate Presentation May 2022 OKYO Corporate Presentation May 2022
OKYO Corporate Presentation May 2022
 
Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019Daily Derivatives Report:28 Feb 2019
Daily Derivatives Report:28 Feb 2019
 
Il&fs
Il&fsIl&fs
Il&fs
 
Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019Weekly Derivatives Report :21 January 2019
Weekly Derivatives Report :21 January 2019
 
Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019Daily Derivatives Report:24 January 2019
Daily Derivatives Report:24 January 2019
 
Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018Daily Derivatives Report:23 October 2018
Daily Derivatives Report:23 October 2018
 
Daily Derivatives Report:22 November 2018
Daily Derivatives Report:22 November 2018Daily Derivatives Report:22 November 2018
Daily Derivatives Report:22 November 2018
 
Daily Derivatives Report:11 January 2019
Daily Derivatives Report:11 January 2019Daily Derivatives Report:11 January 2019
Daily Derivatives Report:11 January 2019
 
Daily Derivatives Report:02 January 2019
Daily Derivatives Report:02 January 2019Daily Derivatives Report:02 January 2019
Daily Derivatives Report:02 January 2019
 
Weekly Derivatives Report :28 January 2019
Weekly Derivatives Report :28 January 2019Weekly Derivatives Report :28 January 2019
Weekly Derivatives Report :28 January 2019
 
Beat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century FinancialBeat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century Financial
 
Beat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century FinancialBeat FDs with US Treasuries | Century Financial
Beat FDs with US Treasuries | Century Financial
 
Weekly Derivatives Report :29 October 2018
Weekly Derivatives Report :29 October 2018Weekly Derivatives Report :29 October 2018
Weekly Derivatives Report :29 October 2018
 
Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019Daily Derivatives Report:22 January 2019
Daily Derivatives Report:22 January 2019
 
Mr. Sumeet Bagadia View on Asian Paints
Mr. Sumeet Bagadia View on Asian PaintsMr. Sumeet Bagadia View on Asian Paints
Mr. Sumeet Bagadia View on Asian Paints
 
SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth SBI: Buy for a target of Rs3480 - Way2wealth
SBI: Buy for a target of Rs3480 - Way2wealth
 
Daily Derivatives Report:24 October 2018
Daily Derivatives Report:24 October 2018Daily Derivatives Report:24 October 2018
Daily Derivatives Report:24 October 2018
 
Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019Daily Derivatives Report:18 Janurary 2019
Daily Derivatives Report:18 Janurary 2019
 

More from IndiaNotes.com

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15IndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaIndiaNotes.com
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesIndiaNotes.com
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoIndiaNotes.com
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityIndiaNotes.com
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16IndiaNotes.com
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtIndiaNotes.com
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...IndiaNotes.com
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...IndiaNotes.com
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CAREIndiaNotes.com
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...IndiaNotes.com
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16EIndiaNotes.com
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15IndiaNotes.com
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...IndiaNotes.com
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyIndiaNotes.com
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15IndiaNotes.com
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndiaNotes.com
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15IndiaNotes.com
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyIndiaNotes.com
 

More from IndiaNotes.com (20)

Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15Fce glaxo smithkline_12aug15
Fce glaxo smithkline_12aug15
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across IndiaGSK Consumer: Horlicks strengthens its position as No.1 brand across India
GSK Consumer: Horlicks strengthens its position as No.1 brand across India
 
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccinesHester Biosciences gets manufacturing licence for 2 additional poultry vaccines
Hester Biosciences gets manufacturing licence for 2 additional poultry vaccines
 
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters alsoVidhi Dyestuffs: To keep its growth story in the coming quarters also
Vidhi Dyestuffs: To keep its growth story in the coming quarters also
 
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacityApollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
Apollo Tyres approves further expansion of the Truck & Bus radial tyre capacity
 
Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16Grasim Industries reports improved performance in Q1FY16
Grasim Industries reports improved performance in Q1FY16
 
Cummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debtCummins India: No interest burden being free from long-term or short-term debt
Cummins India: No interest burden being free from long-term or short-term debt
 
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
Buy Makers Laboratories, company growing rapidly with strong thrust on brande...
 
Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...Buy Multibase India, globalisation of the auto component sector to benefit th...
Buy Multibase India, globalisation of the auto component sector to benefit th...
 
Capital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARECapital First: Long-term credit rating is rated highly at AA+ by CARE
Capital First: Long-term credit rating is rated highly at AA+ by CARE
 
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
Orient Cement: Best placed to benefit from demand revival in AP & Telengana r...
 
Canara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16ECanara Bank's operating performance to improve in remaining 9MFY16E
Canara Bank's operating performance to improve in remaining 9MFY16E
 
Nirmal lupin 06_aug15
Nirmal lupin 06_aug15Nirmal lupin 06_aug15
Nirmal lupin 06_aug15
 
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
Buy Jenburkt Pharmaceuticals; government's amended FDI policy to cover medica...
 
Hexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, BuyHexaware Technologies adds 9 clients in Q2CY15, Buy
Hexaware Technologies adds 9 clients in Q2CY15, Buy
 
Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15Nirmal pi industries_03_aug15
Nirmal pi industries_03_aug15
 
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; HoldIndoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
Indoco Remedies: Weak domestic growth offsets export revenues in Q1FY16; Hold
 
Fce thermax 31_jul15
Fce thermax 31_jul15Fce thermax 31_jul15
Fce thermax 31_jul15
 
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; BuyPI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
PI Industries: Custom synthesis exports deliver growth of ~26% in Q1FY16; Buy
 

Recently uploaded

The Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfThe Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfGale Pooley
 
00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptxFinTech Belgium
 
VIP Call Girls Thane Sia 8617697112 Independent Escort Service Thane
VIP Call Girls Thane Sia 8617697112 Independent Escort Service ThaneVIP Call Girls Thane Sia 8617697112 Independent Escort Service Thane
VIP Call Girls Thane Sia 8617697112 Independent Escort Service ThaneCall girls in Ahmedabad High profile
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfGale Pooley
 
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxOAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxhiddenlevers
 
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...makika9823
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Roomdivyansh0kumar0
 
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdfFinTech Belgium
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdfAdnet Communications
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designsegoetzinger
 
Instant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School SpiritInstant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School Spiritegoetzinger
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escortsranjana rawat
 
Malad Call Girl in Services 9892124323 | ₹,4500 With Room Free Delivery
Malad Call Girl in Services  9892124323 | ₹,4500 With Room Free DeliveryMalad Call Girl in Services  9892124323 | ₹,4500 With Room Free Delivery
Malad Call Girl in Services 9892124323 | ₹,4500 With Room Free DeliveryPooja Nehwal
 
The Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdfThe Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdfGale Pooley
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptxFinTech Belgium
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptxFinTech Belgium
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesMarketing847413
 

Recently uploaded (20)

The Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdfThe Economic History of the U.S. Lecture 19.pdf
The Economic History of the U.S. Lecture 19.pdf
 
00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx00_Main ppt_MeetupDORA&CyberSecurity.pptx
00_Main ppt_MeetupDORA&CyberSecurity.pptx
 
VIP Call Girls Thane Sia 8617697112 Independent Escort Service Thane
VIP Call Girls Thane Sia 8617697112 Independent Escort Service ThaneVIP Call Girls Thane Sia 8617697112 Independent Escort Service Thane
VIP Call Girls Thane Sia 8617697112 Independent Escort Service Thane
 
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur EscortsHigh Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
High Class Call Girls Nagpur Grishma Call 7001035870 Meet With Nagpur Escorts
 
The Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdfThe Economic History of the U.S. Lecture 17.pdf
The Economic History of the U.S. Lecture 17.pdf
 
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptxOAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
OAT_RI_Ep19 WeighingTheRisks_Apr24_TheYellowMetal.pptx
 
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
Independent Lucknow Call Girls 8923113531WhatsApp Lucknow Call Girls make you...
 
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With RoomVIP Kolkata Call Girl Jodhpur Park 👉 8250192130  Available With Room
VIP Kolkata Call Girl Jodhpur Park 👉 8250192130 Available With Room
 
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
06_Joeri Van Speybroek_Dell_MeetupDora&Cybersecurity.pdf
 
20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf20240417-Calibre-April-2024-Investor-Presentation.pdf
20240417-Calibre-April-2024-Investor-Presentation.pdf
 
Instant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School DesignsInstant Issue Debit Cards - School Designs
Instant Issue Debit Cards - School Designs
 
Instant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School SpiritInstant Issue Debit Cards - High School Spirit
Instant Issue Debit Cards - High School Spirit
 
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur EscortsCall Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
Call Girls Service Nagpur Maya Call 7001035870 Meet With Nagpur Escorts
 
Malad Call Girl in Services 9892124323 | ₹,4500 With Room Free Delivery
Malad Call Girl in Services  9892124323 | ₹,4500 With Room Free DeliveryMalad Call Girl in Services  9892124323 | ₹,4500 With Room Free Delivery
Malad Call Girl in Services 9892124323 | ₹,4500 With Room Free Delivery
 
The Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdfThe Economic History of the U.S. Lecture 20.pdf
The Economic History of the U.S. Lecture 20.pdf
 
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
02_Fabio Colombo_Accenture_MeetupDora&Cybersecurity.pptx
 
03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx03_Emmanuel Ndiaye_Degroof Petercam.pptx
03_Emmanuel Ndiaye_Degroof Petercam.pptx
 
Q3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast SlidesQ3 2024 Earnings Conference Call and Webcast Slides
Q3 2024 Earnings Conference Call and Webcast Slides
 
Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024Commercial Bank Economic Capsule - April 2024
Commercial Bank Economic Capsule - April 2024
 
Veritas Interim Report 1 January–31 March 2024
Veritas Interim Report 1 January–31 March 2024Veritas Interim Report 1 January–31 March 2024
Veritas Interim Report 1 January–31 March 2024
 

Way2Wealth's technical pick: Go long on GAIL only above 404 for target of 480

  • 1. I EQUITIES I I GAIL (INDIA) LTD I Special Report WAY2WEALTH Brokers Private Ltd., - Email: research@way2wealth.com website: www.way2wealth.com No. 14, Frontline Granduer, Walton Road, Bangalore-560001 Way2wealth Research is also available on Bloomberg WTWL <GO> 16 June 2015 Given below are the monthly and weekly charts of GAIL (INDIA) LTD which illustrates that the counter has been in the correction mode right from Oct 2014 till the month of April 2015. During the process, the stock shaved off more than 35% from the all-time high of 551.90 and made the immediate swing low of 353.35. Now, at this point in time the stock is once again above the 400 mark. The important point to notice over here is that the prices inverted exactly from the multiple support zone of 357 – 347 which has been braced with many crucial stalling points like ’89 –Month EMA’ and also the 61.8% FIB retracement level of the entire move from 272 to 551.90. After reversing from the discussed stage, stock has made ‘Higher High and Higher Low’ on the weekly chart which indicates likelihood of change in trend. In today’s session, a move above landmark of 400 has resulted in a bullish pattern which resembles a ‘Cup and Handle’. Also, the counter managed to cross the hurdle of ’89 – EMA’ on weekly as well as daily chart. Coming back to the monthly chart, we have also displayed the ‘Heikin-Ashi’ chart of GAIL. It is evident from the given chart that the ‘Heikin-Ashi’ candle is changing its color from RED to BLUE. This is a super bullish sign coupled with positive placement of momentum oscillators. Due to the mentioned technical evidences we are of the opinion that the stock has many rationale to show a sharp upside momentum in the upcoming sessions. Therefore, we advise traders to go long in the GAIL above 404 for an upside target of 480 in medium term. Investment Strategy: Buy ONLY above 404 with a stop loss of 368 for a Target of 480. Risk/return ratio: 1:2.1
  • 2. Special Report I GAIL (INDIA) LTD I WAY2WEALTH Brokers Private Ltd., CIN U67120KA2000PTC027628 - Email: research@way2wealth.com website: www.way2wealth.com No. 14, Frontline Granduer, Walton Road, Bangalore-560001 Way2wealth Research is also available on Bloomberg WTWL <GO> Disclaimer Analyst Certification: I, Mehul Kothari, the research analyst and author of this report, hereby certify that the views expressed in this research report accurately reflect our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s), principally responsible for the preparation of this research report, receives compensation based on overall revenues of the company (Way2Wealth Brokers Private Limited, hereinafter referred to as Way2Wealth) and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. It is confirmed that Mehul Kothari, the author of this report has not received any compensation from the companies mentioned in the report in the preceding 12 months. Our research professionals are paid in part based on the profitability of Way2Wealth, which include earnings from other business. Neither Way2Wealth nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profits that may arise from or in connection with the use of the information contained in this report. Disclaimer This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. Way2Wealth is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. The contents of this material are general and are neither comprehensive nor appropriate for every individual and are solely for the informational purposes of the readers. This material does not take into account the specific objectives, financial situation or needs of an individual/s or a Corporate/s or any entity/s. This research has been prepared for the general use of the clients of the Way2Wealth and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. Way2Wealth will not treat recipients as customers by virtue of their receiving this report. The distribution of this document in other jurisdictions may be restricted by the law applicable in the relevant jurisdictions and persons into whose possession this document comes should inform themselves about, and observe any such restrictions. The report is based upon information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up to date and it should not be relied upon as such. Way2Wealth or any of its affiliates or employees makes no warranties, either express or implied of any kind regarding any matter pertaining to this report, including, but not limited to warranties of suitability, fitness for a particular purpose, accuracy, timeliness, completeness or non-infringement. We accept no obligation to correct or update the information or opinions in it. Way2Wealth or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. The recipients of this report should rely on their own investigations. In no event shall Way2Wealth be liable for any damages of any kind, including, but not limited to, indirect, special, incidental, consequential, punitive, lost profits, or lost opportunity, whether or not Way2Wealth has advised of the possibility of such damages. This material contains statements that are forward-looking; such statements are based upon the current beliefs and expectations and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements. These uncertainties include but are not limited to: the risk of adverse movements or volatility in the securities markets or in interest or foreign exchange rates or indices; adverse impact from an economic slowdown; downturn in domestic or foreign securities and trading conditions or markets; increased competition; unfavorable political and diplomatic developments; change in the governmental or regulatory policies; failure of a corporate event and such others. This is not an offer to buy or sell or a solicitation of an offer to buy or sell any security or instrument or to participate in any particular trading strategy. No part of this material may be copied or duplicated in any form by any means or redistributed without the written consent of Way2Wealth. In no event shall any reader publish, retransmit, redistribute or otherwise reproduce any information provided by Way2Wealth in any format to anyone. Way2Wealth and its affiliates, officers, directors and employees including persons involved in the preparation or issuance of this report may from time to time have interest in securities / positions, financial or otherwise in the securities related to the information contained in this report. To enhance transparency, Way2Wealth has incorporated a Disclosure of Interest Statement in this document. This should, however, not be treated as endorsement of the views expressed in the report.